Surya Singh, MD, is a highly experienced healthcare executive currently serving as CEO at InformedDNA and Senior Advisor at the Institute for Clinical and Economic Review. As President of Singh Healthcare Advisors, Surya Singh provides consultancy services focusing on medical policy, genomics, and product innovation. Previous roles include Co-Founder and CEO of gWell, Attending Physician at Brigham and Women's/Faulkner Hospitals, and Chief Medical Officer at CVS Health, where leadership was demonstrated in managing a significant specialty pharmacy division during rapid growth. Surya Singh's background also includes clinical product development as Chief Medical Officer at Proventys and D2Hawkeye, as well as engagement management at McKinsey and Company. Education includes an M.D. from The Johns Hopkins University School of Medicine and a BS in Molecular Biology from The University of Texas at Austin.
This person is not in any teams
Institute for Clinical and Economic Review (ICER)
The Institute for Clinical and Economic Review (ICER) is an independent, non-profit research institute that conducts evidence-based reviews of health care interventions, including prescription drugs, other treatments, and diagnostic tests. In collaboration with patients, clinical experts, and other key stakeholders, ICER analyzes the available evidence on the benefits and risks of these interventions to measure their value and suggest fair prices. ICER also regularly reports on the barriers to care for patients and recommends solutions to ensure fair access to prescription drugs. For more information about ICER, please visit www.icer.org.